Metabolix (MBLX) Reports Q4 Loss of $0.22/Share
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/15/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- SanDisk upgraded at JPMorgan after investor day; shares climb
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
Metabolix Announces Fourth Quarter and Full Year 2015 Financial Results
March 29, 2016 4:07 PM EDTCAMBRIDGE, Mass., March 29, 2016 (GLOBE NEWSWIRE) -- Metabolix, Inc. (NASDAQ: MBLX), an advanced biomaterials company focused on sustainable solutions for the plastics industry, today reported financial results for the three months and full year ended December 31, 2015.
2015 was an important transition year for Metabolix. We completed a comprehensive reshaping and repositioning of the company around a specialties strategy based on our differentiated PHA biopolymer materials, said Joseph Shaulson, president and CEO of Metabolix. Throughout the year, we focused on building and advancing the portfolio of customer projects in our target application spaces and executed... More
